Clinical Trial Update: Time Course of the Antiproteinuric and Blood Pressure Lowering Effects After Initiation of Renin Inhibition With Aliskiren in Type 2 Diabetes [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update describing the time course of antiproteinuric and blood pressure–lowering effects after initiating aliskiren (renin inhibitor) in individu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Tekturna (aliskiren)

Snippet

Sponsor: Novartis | Conditions: Diabetes Type 2 | Phase 1, Phase 2 | Status: COMPLETED